06/05/2025
6:27 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
5:13 PM | Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2025
3:46 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2025
3:37 PM | Gyre Therapeutics (Filer)
| Form 424B5 | |
05/22/2025
4:27 PM | Gyre Therapeutics (Filer)
| Form 424B5 | |
05/14/2025
7:21 PM | Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
7:30 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2025
6:05 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
12:44 PM | Gyre Therapeutics (Filer)
| Form ARS | |
04/21/2025
4:23 PM | Gyre Therapeutics (Filer)
| Form DEF 14A | |
04/21/2025
4:23 PM | Gyre Therapeutics (Filer)
| Form DEFA14A | |
Get the Latest News and Ratings for GYRE and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
03/20/2025
3:01 PM | Gyre Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/17/2025
3:15 PM | Gyre Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2025
7:00 PM | Gyre Therapeutics (Issuer)
Ye Weiguo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
3:02 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
5:01 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
7:45 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/04/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/21/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
3:05 PM | Gyre Therapeutics (Issuer)
Zhang Ping (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
6:05 AM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2025
3:06 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/24/2024
11:15 PM | Gyre Therapeutics (Filer)
| Form EFFECT | |
11/13/2024
3:05 PM | Gyre Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
7:45 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
7:31 AM | Gyre Therapeutics (Subject)
Ma Songjiang (Filed by)
| Form SC 13D | |
09/06/2024
7:15 AM | Gyre Therapeutics (Subject)
Luo Ying (Filed by)
| Form SC 13D | |
08/16/2024
8:13 PM | Gyre Therapeutics (Issuer)
Nussbaum Rodney L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:53 PM | Chen Ruoyu (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:56 PM | Gyre Therapeutics (Issuer)
Luo Ying (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:58 PM | Eastling Thomas Wilson (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:01 PM | Gyre Therapeutics (Issuer)
Ma Songjiang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:05 PM | Carmichael Gordon (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
8:07 PM | Epstein David M. (Reporting)
Gyre Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
HIDDEN IN THE BOOK OF GENESIS… (Ad) “This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth.
Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation. Watch Jim Rickards reveal the Old Testament Wealth Code |
08/16/2024
8:10 PM | Gyre Therapeutics (Issuer)
Parry Renate (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:50 PM | Gyre Therapeutics (Issuer)
Ying Han (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
8:04 PM | Gyre Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
3:23 PM | Epstein David M. (Reporting)
Gyre Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
